Ophthal Medical News about conjunctiva

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Transplant + Vaccine Therapy Benefits High-Risk Leukemia Patients

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Circulating Breast Cancer Cells Validated as Index of Metastases

Sara Hartley

Cancer Science

HPV Prevalence at Root of Racial Disparity in Head and Neck Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Preliminary Results of Subconjunctival Bevacizumab in Primary Pterygium Excision
Ophthalmic Research, 10/29/09

Razeghinejad MR et al. – A single intraoperative subconjunctival bevacizumab injection had no effect on recurrence rate or early postoperative conjunctival erythema, lacrimation, photophobia or healing of corneal epithelial defects following pterygium excision.

<< Previous
Health expenditure and income in the United States

Next >>
Evaluation of Sub-Tenon Triamcinolone Acetonide Injections in the...